AlphaCentric Advisors LLC — 13F Holdings & Portfolio

CIK 1913464 · latest 13F-HR filed 2026-07-24

AlphaCentric Advisors LLC manages $118.0M in 13F-reported U.S. long-equity assets across 261 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are GILD (2.19%), VRTX (2.11%), INVH (1.87%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 35 new positions, exited 28, added to 140, and trimmed 54.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
207 CALLE DE PARQUE ST.
SAN JUAN 00912
Phone
(631) 629-4907
Filing Manager
AlphaCentric Advisors LLC
SAN JUAN, PR
Signatory
Robert Glass
Chief Compliance Officer
Loading holdings…
AUM

$118.0M

Long-equity book

Holdings

261

Distinct positions

Period

2026-06-30

Filed 2026-07-24

Q/Q Activity

+35 / −28 / ↑140 / ↓54

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • AEVA TECHNOLOGIES INC$778.0K +118.2%
  • UNUSUAL MACHS INC$681.0K +156.9%
  • PERSONALIS INC$649.7K +159.3%
  • APOGEE THERAPEUTICS INC$573.8K +60.0%
  • AXSOME THERAPEUTICS INC.$510.4K +46.9%
Show all 140

Top Trims

  • INVESCO EXCHANGE TRADED FD T-$1.2M -46.2%
  • ISHARES TR-$1.1M -44.6%
  • INGRAM MICRO HLDG CORP-$747.3K -91.6%
  • AMREP CORP-$518.8K -41.4%
  • ISHARES TR-$411.4K -53.7%
Show all 54

New Positions

  • INVESCO QQQ TR$1.4M
  • INVESCO EXCH TRADED FD TR II$1.4M
  • ASCENDIS PHARMA A/S$1.2M
  • HOWARD HUGHES HOLDINGS INC$1.1M
  • MAGNUM ICE CREAM CO NV$696.4K
Show all 35

Exited Positions

  • ASCENDIS PHARMA A/S$1.0M
  • BRAEMAR HOTELS & RESORTS INC$985.0K
  • WHITESTONE REIT$460.1K
  • REZOLVE AI PLC$384.0K
  • BIGBEAR AI HLDGS INC$264.0K
Show all 28
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 GILEAD SCIENCES INC GILD 375558103 $2.6M 2.19% 20,426 SH
2 VERTEX PHARMACEUTICALS INC VRTX 92532F100 $2.5M 2.11% 5,002 SH
3 INVITATION HOMES INC INVH 46187W107 $2.2M 1.87% 73,000 SH
4 ASTRAZENECA PLC AZN G0593M107 $2.2M 1.83% 11,394 SH
5 ROIVANT SCIENCES LTD ROIV G76279101 $1.7M 1.45% 48,355 SH
6 ARGENX SE ARGX 04016X101 $1.7M 1.42% 1,806 SH
7 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $1.6M 1.39% 9,727 SH
8 INCYTE CORP INCY 45337C102 $1.6M 1.39% 14,451 SH
9 AXSOME THERAPEUTICS INC. AXSM 05464T104 $1.6M 1.35% 6,531 SH
10 APOGEE THERAPEUTICS INC APGE 03770N101 $1.5M 1.30% 11,533 SH
11 EURONET WORLDWIDE INC EEFT 298736109 $1.5M 1.24% 20,000 SH
12 AEVA TECHNOLOGIES INC AEVA 00835Q202 $1.4M 1.22% 50,000 SH
13 ISHARES TR IWD 464287598 $1.4M 1.19% 5,771 SH
14 INVESCO EXCHANGE TRADED FD T RPV 46137V258 $1.4M 1.17% 12,122 SH
15 INVESCO QQQ TR QQQ 46090E103 $1.4M 1.16% 1,860 SH
16 INVESCO EXCH TRADED FD TR II QQQM 46138G649 $1.4M 1.16% 4,518 SH
17 SAUL CTRS INC BFS 804395101 $1.3M 1.11% 35,000 SH
18 IONIS PHARMACEUTICALS INC IONS 462222100 $1.2M 1.04% 15,430 SH
19 ASCENDIS PHARMA A/S ASND K08588103 $1.2M 1.04% 4,585 SH
20 INSMED INC INSM 457669307 $1.2M 1.03% 11,394 SH
21 PROTAGONIST THERAPEUTICS INC PTGX 74366E102 $1.1M 0.95% 9,171 SH
22 BUILDERS FIRSTSOURCE INC BLDR 12008R107 $1.1M 0.95% 12,500 SH
23 UNUSUAL MACHS INC UMAC 91532F102 $1.1M 0.94% 50,000 SH
24 HOWARD HUGHES HOLDINGS INC HHH 44267T102 $1.1M 0.91% 15,000 SH
25 ISHARES TR SHY 464287457 $1.1M 0.90% 12,954 SH
26 PERSONALIS INC PSNL 71535D106 $1.1M 0.90% 78,924 SH
27 RHYTHM PHARMACEUTICALS INC RYTM 76243J105 $1.0M 0.89% 9,449 SH
28 STEREOTAXIS INC STXS 85916J409 $1.0M 0.87% 600,000 SH
29 ROCKWELL AUTOMATION INC ROK 773903109 $990.2K 0.84% 2,000 SH
30 XOMETRY INC XMTR 98423F109 $965.2K 0.82% 10,000 SH
31 ABBVIE INC ABBV 00287Y109 $909.2K 0.77% 3,613 SH
32 JAZZ PHARMACEUTICALS PLC JAZZ G50871105 $870.6K 0.74% 3,613 SH
33 TEMPUS AI INC TEM 88023B103 $869.0K 0.74% 15,000 SH
34 PENNANTPARK INVT CORP PNNT 708062104 $867.5K 0.74% 250,000 SH
35 AMGEN INC AMGN 031162100 $855.3K 0.72% 2,362 SH
36 BIOGEN INC BIIB 09062X103 $840.7K 0.71% 3,891 SH
37 AH RLTY TR INC AHRT 04208T108 $814.2K 0.69% 115,000 SH
38 SMARTSTOP SELF STORAG REIT I SMA 83192D402 $812.5K 0.69% 25,000 SH
39 REDWIRE CORPORATION RDW 75776W103 $795.0K 0.67% 65,000 SH
40 GLOBUS MED INC GMED 379577208 $790.1K 0.67% 10,000 SH
41 CTO RLTY GROWTH INC NEW CTO 22948Q101 $752.9K 0.64% 35,000 SH
42 CATALYST PHARMACEUTICALS INC CPRX 14888U101 $742.4K 0.63% 23,622 SH
43 ONDAS INC ONDS 68236H204 $741.6K 0.63% 90,000 SH
44 AMERICAN ASSETS TR INC AAT 024013104 $740.7K 0.63% 30,000 SH
45 HALOZYME THERAPEUTICS INC HALO 40637H109 $737.8K 0.63% 9,426 SH
46 MEIRAGTX HLDGS PLC MGTX G59665102 $735.9K 0.62% 54,469 SH
47 AMREP CORP AXR 032159105 $732.9K 0.62% 29,060 SH
48 KRYSTAL BIOTECH INC KRYS 501147102 $722.9K 0.61% 1,945 SH
49 MAGNUM ICE CREAM CO NV MICC N5505D105 $696.4K 0.59% 40,000 SH
50 MANHATTAN ASSOCIATES INC MANH 562750109 $696.2K 0.59% 5,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-07-24 $118.0M 261 0001580642-26-004575
2026-03-31 2026-05-07 $100.1M 252 0001580642-26-003040
2025-12-31 2026-02-12 $100.3M 250 0001580642-26-001010